from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2342/-

LFCtreatmentdescriptionclass of inhibitor

0.074

Amikacinug/mL Amikacintranslation

0.227

Cap5-10ug/mL Capreomycintranslation

0.006

Rox10-50 ug/mL Roxithromycintranslation

-0.702

SM2-5 ug/mL Streptomycintranslation

0.745

Tet5-10 ug/mL Tetracyclinetranslation

-1.370

Rif0.2-5ug/mL Rifampicintranscription

-0.863

Rifp0.1-0.5ug/mL Rifapentinetranscription

3.206

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

3.186

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.905

CPZ10-50 ug/mL Chlorpromazinerespiration

0.740

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.069

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.305

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.741

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.842

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.131

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.090

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.130

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.768

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.857

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.289

KCN5-20 ug/mL Potassium cyaniderespiration

0.142

NaN30.2-2 mM Sodium aziderespiration

-0.377

Nigericin50 uM Nigericinrespiration

1.309

TRC10-150 ug/mL Triclosanrespiration

1.482

TRZ10-25 ug/mL Thioridazinerespiration

-1.792

Valinomycin0.5-10 uM Valinomycinrespiration

-0.804

ZnSO42 mM ZnSO4respiration

-0.749

menadione6-10 ug/mL Menadionerespiration

0.147

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.344

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.142

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.581

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.077

NRP_1Non-replicating persistence stage 1dosRassociated

-0.094

Amp0.2mg/mL AmpicillincellWall

-0.222

Cephalexin20-100 ug/mL CephalexincellWall

-0.663

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.646

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.269

EMB10-20 ug/mL EthambutolcellWall

0.016

Eta12-40 ug/mL EthionamidecellWall

0.228

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.024

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.009

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.432

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.362

BZA0.12 mg/mL BenzamidearomaticAmides

-0.084

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.703

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.761

H2O24 mM hydrogen peroxideDNAdamaging

-0.596

Levo10 ug/mL LevofloxacinDNAdamaging

-0.344

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.260

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.503

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.465

UVUV-irradiationDNAdamaging

0.170

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.317

Antimycin12.5-50 ug/mL Antimycin A?

-0.441

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.651

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.401

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.973

PA8240.2-2 ug/mL PA-824?

-0.518

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.301

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.471

Verapamil50 uM Verapamil?

-0.373

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.386

methoxatin10-20 ug/mL Methoxatin?